Fig. 2From: Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort studyKaplan Meier Curve for progression-free survival and overall survival of whole groupBack to article page